新規ブラジキニンＢ２受容体アンタゴニスト

Title:

新規ブラジキニンＢ２受容体アンタゴニスト

Document Type and Number:

Japanese Patent JP7164619

Kind Code:

B2

Abstract:

The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament.

More Like This:

JP4237822	Methods and compositions for the treatment of allergic rhinitis and other diseases with descarboethoxyloratadine
JPH01175935	FREEZE-DRIED INJECTION
WO/1992/020642	BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE

Inventors:

gibson christoph
Saupe Joan
Ambrosi Horst-Dieter
Haustedt Lars Ole

Application Number:

JP2020545875A

Publication Date:

November 01, 2022

Filing Date:

November 23, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

PHARVARIS NETHERLANDS B.V.

International Classes:

C07D401/04; A61K9/06; A61K9/08; A61K9/107; A61K9/12; A61K9/20; A61K9/48; A61K9/70; A61K31/4709; A61K31/5377; A61P1/18; A61P11/02; A61P11/06; A61P19/02; A61P25/00; A61P25/28; A61P29/00; A61P37/08; A61P43/00; C07D405/14; C07D413/14; C07D417/14

Domestic Patent References:

JP2000509066A

Foreign References:

WO2008116620A1

Attorney, Agent or Firm:

Patent Attorney Showa International Patent Office

Previous Patent: On-board computer equipment in intelligent vehicles and intelligent vehicles

Next Patent: Systems and methods for optimizing shipping box height